Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The company struggled after a clampdown on NHS doctors referring patients for treatment
Thursday 01 Mar 2018 Author: Lisa-Marie Janes

In September, private hospital operator Spire (SPI) revealed lower NHS referrals, dragging on underlying sales and earnings growth. Investors should find out if referrals have recovered when Spire publishes full year results on 2 March.

Rumours are also swirling that Mediclinic (MDC) will sell its 29.9% stake in Spire after the latter rejected a takeover approach.

‹ Previous2018-03-01Next ›